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Orthotopic liver transplantation was performed in 
two groups of dogs; Group I animals consisted of large 
dogs that served as recipients of livers obtained from 
smaller dogs while Group II animals consisted of dogs 
that received liver from donor dogs of nearly the same 
size. The small-for-size livers transplanted into the 
Group I dogs rapidly increased in size over the course 
of 2 weeks until they achieved a size equal to that 
originally present in the larger recipient dogs. In con-
trast, the livers transplanted into dogs of the same size 
as the donors underwent some degree of atrophy. In both 
groups of animals, plasma levels of insulin and glucagon 
and hepatic (graft) activities of thymidine kinase and 
ornithine decarboxylase were followed serially. The 
only difference between the two groups of animals for 
these measures was that the ornithine decarboxylase 
activity rose to a greater degree in the liver that under-
went graft enlargement. These data suggest that recip-
ient size determines, at least in part, liver graft size once 
it is transplanted. These data also suggest that of the 
parameters followed, only ornithine decarboxylase ac-
tivity parallels the finding of growth of the transplanted 
liver. 
Occasionally, in clinical liver transplantation, a liver 
from a small donor is transplanted into a much larger 
recipient because of urgent need and inability of the 
transplanting surgeons to identify a more appropriate 
donor. In such cases, we have noted that the intact 
transplanted organ rapidly increases in size to achieve a 
size comparable to that of a normal liver within a normal 
individual of the size and age as the recipient over a 
period of 2 weeks (1). To investigate the mechanisms 
responsible for this phenomenon, the following studies 
were performed. 
MATERIALS AND ~bqelap 
Animals. Orthotopic liver transplantation (OLTx) was 
performed in two groups of young adult mongrel dogs using a 
modification of the procedure originally described by Starzl et 
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al, (2). The first group of experimental animals consisted of 
seven large dogs weighing 23.7 ± 0.8 kg (S.E.). All dogs in this 
group underwent hepatectomy and were given allograft organs 
obtained from smaller dogs (mixed breed young adults) that 
weighed 13.2 ± 0.4 kg. A second group of animals acting as 
controls underwent hepatectomy and was transplanted with 
organs obtained from young adult animals of the same size 
(recipient animal's weight = 18.7 ± 4.6 kg; donor animal's 
weight = 19.5 ± 4.5 kg). Prior to OLTx, all dogs had a computed 
tomography (CT) scan of their liver to determine their hepatic 
volume using a recently described technique (3). 
Experimental Design. At the time of hepatectomy and 
immediately upon removal from the animal, the weight of the 
livers of all donors and recipient animals was determined by 
weighing the organs to the nearest gram. Following OLTx, 
serial liver volume determinations were obtained by repeat CT 
scanning procedures. In addition, blood samples were obtained 
at predetermined regular intervals for measurement of total 
bilirubin, ALT (or SGPT), glucagon and insulin levels at 0, 2, 
4,6,8,10,12,14 and 30 days. At termination of the experiment, 
the weight of the allograft liver to the nearest gram was deter-
mined immediately upon sacrifice, for all of the animals, by 
reweighing the removed allograft organ. All animals were 
treated with cyclosporine A at a dose of 20 mg per kg per day 
to prevent allograft rejection. 
The entire protocol was repeated in an additional group of 
separate animals for the determination of the hepatic content 
of both ornithine decarboxylase and thymidine kinase and an 
examination of the histopathologic consequences of liver trans-
plantation. 
Liver CT Scanning. CT scans of the liver for volume 
determinations were obtained on a General Electric model 9800 
CT scanner. Serial transverse scans at 1 cm intervals from the 
dome of the liver through the most inferior portion of the organ 
were obtained with the dog's respiration suspended in full 
expiration. Using a track ball device, the perimeter of each slice 
of the liver was outlined, and the enclosed area was calculated 
electronically. Total hepatic volume was obtained by summing 
the volumes of individual slices. Intraobserver error for meas-
uring a single slice or for measuring the total liver volume was 
::::;5%. 
llfeasurements 
1. Serum total bilirubin and AL T levels were measured in 
the clinical laboratories of Presbyterian-University Hos-
pital using standard methods. 
2. Plasma insulin levels were determined by radioimmu-
noassay using an insulin kit obtained from Sera no Diag-
nostics (Boston, Mass.). The detection limit of the assay 
used was 5 .uU per ml. The intra- and interassay variations 
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of the assay method for normal level samples were 6 and 
10%, respectively. 
3. Plasma glucagon levels were determined by radioimmu-
noassay using a glucagon kit obtained from Serono Diag-
nostics (Boston, Mass.). All samples for glucagon meas-
urements were collected in chilled tubes containing 500 
units trasylol and 1.2 mg sodium EDT A per ml blood 
collected. The detection limit for this assay was 15 pg per 
ml. The intra- and interassay variations for normal sam-
ples were 7 and 12%, respectively. 
4. Ornithine decarboxylase activity was determined utilizing 
the method of McGowan and Fausto (4). For this assay, 1 
gm liver tissue was homogenized immediately in 4 ml 
buffer consisting of 0.25 M sucrose, 1.5 roM Na2EDT A, 
10 m.M mercaptoethanol and 10 roM Tris-HCI buffer (pH 
7.4). The resultant homogenate was centrifuged for 50 min 
at 105,000 x g at 4°C. An aliquot of the cytosolic super-
natant solution (0.4 ml) was added to 0.5 ml ornithine 
decarboxylase incubation buffer [10 mM Tris-HCI (pH 
8.0), 0.2 mM pyridoxal phosphate, 5 mM dithiothreitol 
and 1.5 mM L-ornithine] and preincubated for 5 min at 
37°C, at which time 100 iLl (0.5 iLCi) [V'C]ornithine was 
added to the reaction vessel. The vessel was capped, and 
the reaction was maintained at 37°C for 60 min until 
termination by the addition of 100 iLl concentrated tri-
chloroacetic acid. The CO2 released from the ornithine 
was trapped in ethanolamine/ethylene glycol (2/1) and 
subsequently measured in 10 ml of ACS scintillation fluid 
by counting radioactivity on a Tricarb 460 liquid scintil-
lation counter. The detection limit for this assay is 40 cpm 
per hr per mg protein. The coefficient of variation for 
identical samples assayed on different days is <9% (n = 
10). 
5. Thymidine kinase activity was determined utilizing the 
method of Kahn et al. (5). Specifically, 0.5 gm liver was 
homogenized immediately in 5 ml 0.1 M Tris-HCI buffer 
(pH 8.0), and the resultant homogenate was centrifuged 
for 50 min at 105,000 x g at 4°C. The cytosolic supernatant 
(0.2 m!) was incubated with 800 ILl thimidine kinase in-
cubation buffer consisting of 50 mM Tris-HCI (pH 8.0), 5 
mM A TP, 3.6 roM MgCb and 0.01 mM [3H]thymidine for 
10 min at 37°C. The reaction was stopped by immersion 
of the reaction vessel in boiling water for 2 min. Control 
assays consisting of incubation mixtures which had been 
immediately placed in boiling water were performed for 
all samples. Denatured protein was removed by centrifu-
gation at 100 X g for 10 min and 100 ILl of the resultant 
supernatant were spotted on DEAE cellulose paper. The 
paper was then washed consecutively in 1 roM ammonium 
formate (5 min), distilled water (3 min) and the sequence 
was repeated again. The washed paper was placed in a 
scintillation vial to which 1 ml 0.1 M HCI and 0.2 M KCI 
was added. The vial was capped and shaken for 15 min. 
ACS (10 mll was then added and the radioactivity counted 
on a Tricarb 460 liquid scintillation counter. The detection 
limit for this assay is 15 fmoles per mg per min. The 
coefficient of variation for similar samples assayed as 
different days is <11 % (n = 10). 
6. Protein determinations were performed using the method 
of Lowry (6) using bovine serum albumin as the standard. 
Histological Preparation and Examination of the 
Liver. At the time of sacrifice, specimens of liver tissue were 
obtained and fixed in 10% formalin and then embedded in 
paraffin. Sections 4 /Lm thick were cut and stained with hema-
toxylin-eosin. The sections were examined for evidence of 
regeneration as evidenced by the numbers of mitoses and 
multinucleated hepatocytes present within representative sec-
tions of Zones I and III. 
Statistical Analysis. All results are reported as mean values 
± S.E. All statistical analyses were performed using a two-
tailed Student's t test. A p value < 0.05 was considered to be 
significant. 
RESULTS 
In the first group of seven large dogs having a mean 
body weight of 23.7 ± 0.8 kg and a mean hepatic weight 
of 767 ± 48 gm, a liver obtained from 1 of 7 smaller dogs 
having a mean body weight of 13.2 ± 0.4 kg and a mean 
liver weight of 363 ± 20 gm was engrafted. The subse-
quent growth of the small-for-size liver in the larger 
recipient animals was followed for various lengths of 
time. Three dogs were allowed to live for a full 30 days 
following OLTx, at which time they were killed and the 
liver grafts were removed and reweighed. The four other 
large dogs transplanted either were sacrificed or died at 
earlier time points (10, 11, 13 and 31 days). In each case, 
however, the graft liver was removed and reweighed. 
Figure 1 (Parts 1 and 2) demonstrates the serial liver 
volumes determined by CT scanning in two of the 3- to 
30-day surviving dogs which received a small-for-size 
organ graft. The four animals that survived for shorter 
periods showed similar changes in liver volume over time 
and were examined after intervals of 10, 11, 13 and 31 
days as noted earlier .. Table 1 shows the growth of the 
transplanted small-for-size organs presented as per cent 
volume change over time for all seven of the animals 
studied. 
In the second group of three animals having a mean 
body weight of 18.7 ± 4.6 kg and a mean liver volume of 
482 ± 114 gm, the livers obtained from similar-sized dogs 
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FIG. 1. Growth of a small-far-size liver transplanted into a larger 
recipient. Each component part identified as 1 and 2 shows the data 
for a separate experiment. The ordinate for each graph shows liver 
volume. The abscissa shows time postliver transplantation in days. The 
solid horizontal line represents the size of the recipient's own liver prior 
to hepatectomy. The open circles represent the liver volume of the 
small-far-size organ transplanted into the larger recipient. The oblique 
line represents the best line obtained using least squares analysis for 
fit of the data obtained. 
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TABLE 1. Growth of an intact small-for-size organ in a larger 
recipient animal 
Day posttransplant 
2 
4 
6 
8 
10 
12 
14 
20 
30 
CD 
800 l 
::[ 
% increase in liver volume 
33 ± 6 
58 ± 8 
125 ± 15 
142 ± 12 
164 ± 4 
182 ± 8 
233 ± 10 
221 ± 12 
208 ± 9 
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FIG. 2. Change in size of a normal liver transplanted into a dog of 
similar size. Each component part identified as 1, 2 or 3 represents the 
data for a separate experiment. The ordinate shows liver volume. The 
abscissa shows time in days following transplantation. The open circles 
represent consecutive values obtained for liver volume after transplan-
tation. Note that in each case the transplanted liver atrophies slightly. 
The solid horizontal line represents the recipient animal's liver volume 
prior to transplantation. 
having a mean body weight of 19.5 ± 4.5 kg and a liver 
weight of 523 ± 116 gm were used as the donor organs 
for OLTx. As can be seen from Figure 2 (Parts 1 to 3), 
none of the transplanted organs in the same-sized recip-
ients increased in size. In fact, in the recipient, they all 
decreased slightly in size and weight with time. 
As can be seen in Figure 3 (A and B), little or no 
changes in total bilirubin and a transient increase in 
AL T levels occurred in all of the animals studied. It 
should be noted that, although the bilirubin levels in the 
experimental group are uniformly greater than those in 
the control group for the first 12 days of the experiment, 
none of these differences are significant. 
Similarly, plasma insulin and glucagon levels did not 
differ between the two groups, with insulin levels not 
changing over time and the glucagon level increasing 5-
fold within 48 hr in both groups but then returning to 
normal levels by 96 hr after transplantation (Figure 4, A 
and B). 
Hepatic levels of thymidine kinase increased in both 
groups of transplanted dogs reaching peak levels in 3 to 
4 days. No difference was seen between the two groups 
of transplanted animals, however, either basally or at 
peak levels following transplantation (Figure 5). 
In contrast, although no difference was seen in the 
pretransplant basal levels of ornithine decarboxylase, the 
peak levels observed at 24 hr after transplantation were 
much greater in the experimental Group I animals than 
they were in the control Group II animals (Figure 6). 
Histologically, the livers of the Group I animals all 
showed evidence of panlobular hepatic regeneration 
characterized by double and triple cell thick plates, nu-
merous mitotic figures and moderate numbers of triple-
nucleated hepatocytes. In contrast, the livers of the 
Group II animals showed less evidence for regeneration 
which was limited to the area of Zone III (Table 2). 
DISCUSSION 
The results of the present studies in dogs clearly 
demonstrate that the recipient's size determines the size 
of a transplanted liver in its new host. Moreover, they 
highlight the difference between the terms growth and 
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FIG. 3. Total bilirubin (A) and ALT (SGPT) levels (B) in serum of 
the two groups of animals studied. The experimental group received a 
small·for·size liver. The control group received a normal-sized liver. 
The abscissa shows time since transplantation. 
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FIG. 5. Thymidine kinase levels in the liver of dogs receiving normal 
size liver at time of transplantation (controls) and small-for-size organs 
at time of transplantation (experimental group). Both basal pretrans-
plant and peak values after transplantation are shown. The bars 
represent mean values and the brackets represent S.E. The asterisks 
denote that the peak levels of both groups are significantly greater than 
the respective basal levels (p < 0.001). 
regeneration. In animals that receive a small-for-size 
donor organ, the liver rapidly increases in size or grows 
until it achieves a size nearly identical to that of the 
recipient's own liver prior to hepatectomy (Figures 1 and 
7). In contrast, livers grafted into animals of the same 
size as the recipient actually atrophy slightly, although 
regeneration is evident in these livers (Figures 2 and 7). 
These quite different changes in graft liver size or growth 
occur despite similar changes in serum total bilirubin 
and ALT levels and plasma levels of glucagon and insu-
lin. Moreover, they occur despite similar changes in the 
hepatic content of thymidine kinase activity, the rate-
limiting enzyme in DNA synthesis, over time. The only 
parameter that distinguished between the two groups of 
animals, those receiving small-for-size livers that in-
creased in size and those that received normal-sized 
livers that atrophied, was the hepatic content of orni-
thine decarboxylase which increased in both groups of 
animals studied but more so in those given small-for-size 
donor organs. Thus, these data. suggest that thymidine 
kinase may be a marker for regeneration but that growth 
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FIG. 6. Ornithine decarboxylase levels in the liver of dogs receiving 
normal size livers at the time of transplantation (controls) and small-
for-size organs at the time of transplantation (experimental group). 
Both basal pretransplant and peak values after transplantation are 
shown. The bars represent mean values and the brackets represent S.E. 
TABLE 2. Histologic evidence for regeneration in the liver 
grafts studied 
Small size donor 
group 
Normal size 
donor 
group 
Zone I Zone ill Zone I Zone ill 
Mitosis· 10 ± 1 b.c 15 ± 2c 2 ± 1 5 ± 1 
Multinucleated hepatocytes* 11 ± 1b• c 24 ± 2c 1 ± 0 3 ± 1 
a Per high power field. 
b p < 0.001 compared to Zone III within the same group. 
c p < 0.001 compared to the result for the same zone in the other 
group. 
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occurs only if ornithine decarboxylase is also increased 
above a certain level. Thus, ornithine decarboxylase 
which is known to be important in polyamine synthesis 
may be the putative initiator of growth. It is well-known 
that polyamines are involved in the regulation of rRNA 
synthesis and that blocking ornithine decarboxylase ac-
tivity prevents regrowth of an injured organ presumably 
by preventing polyamine synthesis. (6). 
These data suggest further that the recipient's size 
determines, in large measure, the change in size that a 
liver graft will experience following successful transplan-
tation. Taken together, these data suggest rather strongly 
that the liver growth experienced by a transplanted organ 
is either signaled by or initiated by a marked increase in 
the hepatic content of ornithine decarboxylase and pre-
sumably, although not tested in the present study, by the 
polyamine content of the liver. In contrast, changes in 
the plasma levels of insulin and glucagon or changes in 
the hepatic content of thymidine kinase appear not to 
be important in this regard although the activity of this 
latter enzyme certainly increases and is required for 
hepatic regeneration. 
These data do not negate the considerable data avail-
able suggesting that both insulin and glucagon, as well 
as a host of insulin -like growth factors, are necessary for 
or capable of initiating hepatic regeneration under cer-
tain circumstances (7-29). In contrast, the present data 
extend such data and demonstrate that should the he-
patic mass be appropriate for the metabolic demands of 
the host that despite such signals hepatic regeneration 
leading to hepatic growth does not occur. In contrast, 
when the hepatic mass is too small (inadequate) to meet 
the metabolic demands of the host, signals such as in-
sulin, glucagon and other putative growth factors initiate 
a cascade of intracellular events culminating in a dra-
matic increase in ornithine decarboxylase activity which 
is followed not only by hepatic regeneration replacing 
dead or dying hepatocytes as seen in the controls, but 
also by actual hepatic growth as evidenced by a marked 
increase in the usual signs of hepatic regeneration but 
also and more importantly by an actual increase in the 
hepatic mass as evidenced by hepatic volume and weight 
measures. 
The specific mechanisms responsible for the marked 
increase in the hepatic content of ornithine decarboxyl-
ase in enlarging liver grafts is not as yet known. Moreo-
ver, the sequence of events that either initiates or allows 
hepatic growth to occur in response to an increase in 
hepatic content of ornithine decarboxylase in a trans-
planted liver are also as yet poorly understood. Nonethe-
less, it appears that an increase in ornithine decarbox-
ylase and, presumably, polyamines within the liver oc-
curs and acts as the signal initiating hepatic growth such 
that the liver graft enlarges to a size that approximates 
the size of a normal liver expected to be present in the 
recipient. 
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